Preoperative Body Mass Index May Determine the Prognosis of Advanced Gastric Cancer. (16th November 2016)

• Record Type: Journal Article
• Authors: Jun, Dong Hwan; Kim, Beom Jin; Park, Ji Hoon; Kim, Jae G.; Chi, Kyong-Choun; Park, Joong-Min; Kim, Mi Kyung; Kang, Hyun
• Is Part Of: Nutrition and cancer. Volume 68:Number 8(2016)
• Page Start: 1295
• Page End: 1300
• Publication Date: 2016-11-16
• Subjects: Cancer -- Periodicals; Nutrition -- Periodicals; Cancer; Nutrition; Periodicals; 616.9940654
• DOI: 10.1080/01635581.2016.1224363
• Languages: English
• ISSNs: 0163-5581

Abstract

ABSTRACT: Radical gastrectomy followed by adjuvant chemotherapy for advanced gastric cancer causes serious nutritional impairment. Our study evaluated the clinical impact of body mass index (BMI) on the long-term outcomes of advanced gastric cancer (stage II and III). We analyzed 211 cases of stage II and III gastric cancer between January 2005 and December 2010 at Chung-Ang University Hospital, Seoul, Korea. Patients were divided into four groups according to BMI: underweight, normal, overweight, and obese. In addition, we divided patients into two groups: BMI-High (BMI ≥ 23 kg/m 2 ) vs. BMI-Low (BMI < 23 kg/m 2 ). We assessed age, sex, tumor location, lymph node (LN) involvement, operation method, initial cancer stage, recurrence, and survival between the two groups. There was significant difference in overall survival (OS) between the underweight group and the other groups ( P = 0.005). The survival of the BMI-High group was better than that of the BMI-Low group. The rate of cancer-related death in the BMI-High group was significantly lower than that in the BMI-Low group (cancer-related death: BMI-Low 27% vs. BMI-High 12.6%, P = 0.022). Our findings suggest that preoperative BMI may have an influence on the long-term outcomes of advanced gastric cancer after radical surgery and chemotherapy.